Biotherapeutics have enormous potential to improve human health. The number of approved protein and antibody therapeutics continues to grow around the world as this important therapeutic class addresses unmet medical needs.
But discovery and development of biopharmaceuticals is difficult. You face a variety of challenges and must not only stay abreast of advances in knowledge and improvements in technology, but also navigate the maze of shifting government regulations. Making good decisions fast is critical.
At every stage in the process, from disease research to QA/QC and manufacturing, Agilent can help you make the right choices for moving therapeutics successfully to market. And it’s not just because we build reliable instruments that provide accurate, reproducible results. We understand the biopharmaceutical workflow and provide families of products that work together seamlessly—as engines of research, discovery, and development—to move candidate biopharmaceuticals forward.